Showing results (321-330 of 392) with videos related to
Sort By:
Pageof 40
JAMA Otolaryngology-- Head & Neck Surgery|April 28, 2022
Tumor Histological Grade and Immunotherapy Response in Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaHosam H Alkhatib, Christopher A Maroun, Neha Amin, et al.Head & Neck|November 26, 2021
Neoadjuvant immunotherapy prior to surgery for mucosal head and neck squamous cell carcinoma: Systematic reviewNeha Amin, Christopher A Maroun, Margueritta El Asmar, et al.Plos One|July 19, 2018
Evidence of a positive association between malpractice climate and thyroid cancer incidence in the United StatesBrandon Labarge, Vonn Walter, Eugene J Lengerich, et al.International Journal of Cancer|September 23, 2006
Increased plasma DNA integrity index in head and neck cancer patientsWei-Wen Jiang, Marianna Zahurak, David Goldenberg, et al.The Laryngoscope|March 15, 2018
Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomasLinda X Yin, Gypsyamber D'Souza, William H Westra, et al.Cancer|June 18, 2021
RTOG-0129 risk groups are reproducible in a prospective multicenter heterogeneously treated cohortCarole Fakhry, Sakshi R Tewari, Lisa Zhang, et al.Archives of Otolaryngology--Head & Neck Surgery|January 21, 2004
Intraoperative molecular margin analysis in head and neck cancerDavid Goldenberg, Susan Harden, Brett G Masayesva, et al.International Journal of Cancer|October 30, 2004
Molecular margin analysis predicts local recurrence after sublobar resection of lung cancerBrett G Masasyesva, Betty C Tong, Malcolm V Brock, et al.Plos One|October 3, 2013
Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axisJunaid Abdulghani, Joshua E Allen, David T Dicker, et al.Human Vaccines & Immunotherapeutics|January 17, 2019
Sex differences in HPV immunity among adults without cancerMelina J Windon, Tim Waterboer, Alexander T Hillel, et al.Pageof 40